NFKB1 and oral cavity squamous cell carcinoma: MLN4924 may exert its anti-oral squamous cell carcinoma effect by inhibiting the NFκB pathway and increasing the expression of multiple anti-cancer genes, demonstrating the potential for the treatment of oral squamous cell carcinoma.